(Q56967695)

https://api.crossref.org/works/10.1002%2FEJI.1830270304

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Phenotypically and functionally distinct T-cell subsets in anti-tumor responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

A molecular model of MHC class-I-restricted antigen processing

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Structure of peptides associated with MHC class I molecules.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Induction of H-2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Immunobiology of tissue transplantation: a return to the passenger leukocyte concept

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Introduction of soluble protein into the class I pathway of antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Exact prediction of a natural T cell epitope

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270304

7 January 2021